Author: Hu, Biying; Huang, Shaoying; Yin, Lianghong
Title: The cytokine storm and COVIDâ€19 Cord-id: rvrgcugn Document date: 2020_6_27
ID: rvrgcugn
Snippet: Coronavirus disease 2019 (COVIDâ€19), which began in Wuhan, China in December 2019 has caused a large global pandemic and poses a serious threat to public health. More than four million cases of COVIDâ€19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2), have been confirmed as of May 11, 2020. SARSâ€CoVâ€2 is a highly pathogenic and transmissible coronavirus that primarily spreads through respiratory droplets and close contact. A growing body of clinic
Document: Coronavirus disease 2019 (COVIDâ€19), which began in Wuhan, China in December 2019 has caused a large global pandemic and poses a serious threat to public health. More than four million cases of COVIDâ€19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2), have been confirmed as of May 11, 2020. SARSâ€CoVâ€2 is a highly pathogenic and transmissible coronavirus that primarily spreads through respiratory droplets and close contact. A growing body of clinical data suggests that a cytokine storm is associated with COVIDâ€19 severity and is also a crucial cause of death from COVIDâ€19. In the absence of antivirals and vaccines for COVIDâ€19, there is an urgent need to understand the cytokine storm in COVIDâ€19. Here, we have reviewed the current understanding of the features of SARSâ€CoVâ€2 and the pathological features, pathophysiological mechanisms, and treatments of the cytokine storm induced by COVIDâ€19. Additionally, we suggest that the identification and treatment of the cytokine storm are important components for rescuing patients with severe COVIDâ€19. This article is protected by copyright. All rights reserved.
Search related documents:
Co phrase search for related documents- abnormal activation and acute respiratory syndrome: 1, 2, 3, 4
- abnormal activation and macrophage monocyte: 1
- accepted article and acute respiratory syndrome: 1, 2, 3, 4, 5
- acquire immune and macrophage monocyte: 1
- acute ards respiratory distress syndrome and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and lung detect: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute mortality and liver damage: 1, 2, 3, 4, 5
- acute mortality and lung detect: 1, 2, 3
- acute mortality and macrophage monocyte: 1, 2
- acute respiratory syndrome and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and lung detect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute respiratory syndrome and macrophage monocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- liver damage and macrophage monocyte: 1, 2
Co phrase search for related documents, hyperlinks ordered by date